ArticleHuman gene therapy2020

LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.

Weidong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.